Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

INTRODUCTION: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer (MBC), with overall survival benefits. OBJECTIVE: We evaluated the efficacy of dual HER-2 blockade combined with chemotherapy for HER-2-posit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Care (Basel)
Main Authors: Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2021
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7923938/
https://ncbi.nlm.nih.gov/pubmed/33716633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506824
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki